Release of Mazda Integrated Report 2022

HIROSHIMA, Japan, Dec 5, 2022 – (JCN Newswire via SEAPRWire.com) – Mazda Motor Corporation today released the first Mazda Integrated Report 2022(1), a structured presentation from both financial and non-financial perspectives looking at Mazda’s approach to value creation and other efforts, on the company’s official website. The Integrated Report is a comprehensive compilation of Mazda’s […]

Olympus Announces Launch of Olympus Asia Pacific Innovation Program

SINGAPORE, Dec 5, 2022 – (JCN Newswire via SEAPRWire.com) – Olympus Corporation (Olympus), a global medtech company committed to making people’s lives healthier, safer and more fulfilling, has partnered with MedTech Innovator Asia Pacific, the industry’s largest healthcare accelerator, to facilitate the Olympus Asia Pacific Innovation Program (OAIP) running throughout 2023. Over a century old, […]

DENSO Receives IEEE Corporate Innovation Award for Developing and Spreading Use of QR Code

KARIYA, JAPAN, Dec 2, 2022 – (JCN Newswire via SEAPRWire.com) – DENSO Corporation today announced it has received the IEEE Corporate Innovation Award from IEEE,(1) the largest international association for electrical and electronic engineering in the world, for developing the QR Code(2) and spreading its use globally. The IEEE Corporate Innovation Award, one of the […]

NEC and SINAI Technologies Collaborate to Create Pathways to Decarbonization

Tokyo and San Francisco, Dec 2, 2022 – (JCN Newswire via SEAPRWire.com) – NEC Corporation and SINAI Technologies lnc., a software company that supports the transformation of companies and organizations to achieve their net-zero targets, will commence collaboration on businesses that support decarbonization in November 2022. In December 2021, NEC established an ecosystem-based corporate venture […]

Eisai to Present Preclinical and Clinical Research on Eribulin at the 2022 San Antonio Breast Cancer Symposium

TOKYO, Dec 1, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. announced today that new study results on its in-house discovered and developed anticancer agent eribulin mesylate (HALAVEN, “eribulin”) will be presented during the 2022 San Antonio Breast Cancer Symposium (SABCS), which is taking place virtually and in-person in San Antonio, Texas from […]

Honda Unveils Next-generation Technologies of Honda SENSING 360 and Honda SENSING Elite

TOKYO, Dec 1, 2022 – (JCN Newswire via SEAPRWire.com) – Honda Motor Co., Ltd. today unveiled the next-generation technologies of the Honda SENSING 360 omnidirectional safety and driver-assistive system, and Honda SENSING Elite, a flagship variation of Honda SENSING, respectively. Based on the global safety slogan “Safety for Everyone,” Honda is striving for a collision-free […]

NEC Orchestrating Future Fund, an Ecosystem-type CVC Fund, Completes Final Close for US$140 Million

TOKYO, Nov 30, 2022 – (JCN Newswire via SEAPRWire.com) – NEC Corporation (TSE: 6701) has completed the final close of the “NEC Orchestrating Future Fund”(1), an ecosystem-type corporate venture capital (CVC) fund established in December 2021 for US$140 million (approximately 20 billion yen). This CVC fund was made possible through investments from NTT FINANCE CORPORATION, […]

Mitsubishi Power to Upgrade Two Gas Turbines at Tuas Power to Achieve 16.9 kilo-tonnes of Carbon Emissions Reduction Annually

TOKYO, Nov 30, 2022 – (JCN Newswire via SEAPRWire.com) – Mitsubishi Power, a power solutions brand of Mitsubishi Heavy Industries, Ltd. (MHI), has received a contract from Tuas Power Generation Pte. Ltd., a major power company in Singapore, for upgrades to two of the four M701F gas turbines (CCP3 and CCP4) in its gas turbine […]

ExxonMobil, Mitsubishi Heavy Industries Form Carbon Capture Technology Alliance

TOKYO, Nov 30, 2022 – (JCN Newswire via SEAPRWire.com) – ExxonMobil and Mitsubishi Heavy Industries (MHI) have joined forces to deploy MHI’s leading CO2 capture technology as part of ExxonMobil’s end-to-end carbon capture and storage (CCS) solution for industrial customers. The joint effort combines ExxonMobil’s and MHI’s years of expertise in the industry and strengthens […]

Eisai Presents Full Results of Lecanemab Phase 3 Confirmatory Clarity Ad Study for Early Alzheimer’s Disease at Clinical Trials on Alzheimer’s Disease (CTAD) Conference

TOKYO, Nov 30, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that the results from Eisai’s large global Phase 3 confirmatory Clarity AD clinical study of lecanemab (development code: BAN2401), an investigational anti-amyloid beta (Abeta) protofibril antibody for the treatment of mild cognitive impairment (MCI) due to Alzheimer’s […]

Eleven Experts from Leading Medical Institutions and Eight Experts from Eisai Publish Full Results of Lecanemab Phase 3 Confirmatory Clarity Ad Study for Early Alzheimer’s Disease in the New England Journal of Medicine

TOKYO, Nov 30, 2022 – (JCN Newswire via SEAPRWire.com) – Eisai Co., Ltd. and Biogen Inc. announced today that the results from Eisai’s large global Phase 3 confirmatory Clarity AD clinical study of lecanemab (development code: BAN2401), an investigational anti-amyloid beta (Abeta) protofibril antibody for the treatment of mild cognitive impairment (MCI) due to Alzheimer’s […]